Prospective analysis of endoscopic measurement of pyloric impedance planimetry and its association with clinical outcomes of gastric peroral endoscopic myotomy

Abstract

Background

The functional luminal imaging probe (FLIP) assesses pyloric sphincter physiology. We prospectively used FLIP to evaluate the association between pyloric measurements and clinical outcomes of gastric peroral endoscopic myotomy (G-POEM) in patients with refractory gastroparesis.

Methods

This was a single-center prospective trial of patients who underwent G-POEM between January 2022 and March 2024. FLIP was performed before G-POEM, immediately after G-POEM, and at follow-up (median 6 months). Clinical response was defined as an improvement of ≥1 point on the Gastroparesis Cardinal Symptom Index (GCSI). A receiver operating characteristic curve was constructed to evaluate the relationship between FLIP measurements and response to G-POEM.

Results

Clinical response was achieved in 64/90 patients (71.1%) at a median of 6 months. Mean (SD) FLIP distensibility index (DI) before G-POEM was significantly lower among responders vs. non-responders (7.10 [2.75] vs. 9.24 [3.14] mm2/mmHg; P = 0.002). Mean DI increased significantly in both groups immediately after G-POEM, but this remained elevated only among responders (10.4 [4.4] mm2/mmHg; P < 0.001), returning toward baseline among non-responders (9.7 [4.7] mm2/mmHg; P = 0.69) at 6 months’ follow-up. A DI threshold of 7.35 mm2/mmHg before G-POEM had an area under the curve of 0.72 and yielded a specificity of 80.8% and sensitivity of 60.6%.

Conclusion

Sustained improvement in pyloric FLIP measurements was seen in patients with a clinical response to G-POEM. Patients who responded to G-POEM had a lower baseline DI compared with non-responders. Additional studies optimizing and standardizing FLIP protocols in patients undergoing G-POEM are needed.

• References

• 1 Khashab MA, Wang AY, Cai Q. AGA clinical practice update on gastric peroral endoscopic myotomy for gastroparesis: commentary. Gastroenterology 2023; 164: 1329-1335
• 2 Wadhwa V, Mehta D, Jobanputra Y. et al. Healthcare utilization and costs associated with gastroparesis. World J Gastroenterol 2017; 23: 4428
• 3 Gonzaga ER, Draganov PV, Yang D. Gastric peroral endoscopic myotomy (G-POEM) for the management of gastroparesis. Tech Innov Gastrointest Endosc 2024; 26: 46-55
• 4 Mearin F, Camilleri M, Malagelada JR. Pyloric dysfunction in diabetics with recurrent nausea and vomiting. Gastroenterology 1986; 90: 1919-1925
• 5 Katza DA, Camilleri M. Treating the pylorus in gastroparesis: the new riddle wrapped in the ultimate enigma?. Gastrointest Endosc 2020; 91: 1300-1302
• 6 Desprez C, Melchior C, Wuestenberghs F. et al. Pyloric distensibility measurement predicts symptomatic response to intrapyloric botulinum toxin injection. Gastrointest Endosc 2019; 90: 754-760
• 7 Jacques J, Pagnon L, Hure F. et al. Peroral endoscopic pyloromyotomy is efficacious and safe for refractory gastroparesis: prospective trial with assessment of pyloric function. Endoscopy 2019; 51: 40-49
• 8 Vosoughi K, Ichkhanian Y, Jacques J. et al. Role of endoscopic functional luminal imaging probe in predicting the outcome of gastric peroral endoscopic pyloromyotomy (with video). Gastrointest Endosc 2020; 91: 1289-1299
• 9 Revicki DA, Rentz AM, Dubois D. et al. Gastroparesis Cardinal Symptom Index (GCSI): development and validation of a patient reported assessment of severity of gastroparesis symptoms. Qual Life Res 2004; 13: 833-844
• 10 Abell TL, Camilleri M, Donohoe K. et al. Consensus recommendations for gastric emptying scintigraphy: a joint report of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine. Am J Gastroenterol 2008; 103: 753-763
• 11 Hayat M, Yang D, Draganov PV. Third-space endoscopy: the final frontier. Gastroenterol Rep 2023; 11: goac077
• 12 Khan HM, Brar TS, Hasan MK. et al. Prospective study on the efficacy of endoscopic through-the-scope tack and suture system for gastric peroral endoscopic myotomy mucosal incision site closure. Endosc Int Open 2023; 11: E187-E192
• 13 Yang D, Hasan MK, Bani Fawwaz B. et al. Quantification of interstitial cells of Cajal and fibrosis during gastric per-oral endoscopic myotomy and its association with clinical outcomes. Endosc Int Open 2024; 12: E585-E592
• 14 Yang D, Kadkhodayan K, Arain MA. et al. Novel dual-action tissue through-the-scope clip for endoscopic closure. VideoGIE 2022; 7: 345-347
• 15 Yim B, Gregor L, Siwiec RM. et al. Pyloric functional lumen imaging probe measurements are dependent on balloon position. J Neurogastroenterol Motil 2023; 29: 192-199
• 16 Gregor L, Wo J, DeWitt J. et al. Gastric peroral endoscopic myotomy for the treatment of refractory gastroparesis: a prospective single-center experience with mid-term follow-up (with video). Gastrointest Endosc 2021; 94: 35-44
• 17 Dacha S, Mekaroonkamol P, Li L. et al. Outcomes and quality-of-life assessment after gastric per-oral endoscopic pyloromyotomy (with video). Gastrointest Endosc 2017; 86: 282-289
• 18 Nass KJ, Zwager LW, van der Vlugt M. et al. Novel classification for adverse events in GI endoscopy: the AGREE classification. Gastrointest Endosc 2022; 95: 1078-1085
• 19 Martinek J, Hustak R, Mares J. et al. Endoscopic pyloromyotomy for the treatment of severe and refractory gastroparesis: a pilot, randomized, sham-controlled trial. Gut 2022; 71: 2170-2178
• 20 Gonzalez JM, Mion F, Pioche M. et al. Gastric peroral endoscopic myotomy versus botulinum toxin injection for the treatment of refractory gastroparesis: results of a double-blind randomized controlled study. Endoscopy 2024; 56: 345-352
• 21 Hernández Mondragón OV, Contreras LFG, Velasco GB. et al. Gastric peroral endoscopic myotomy outcomes after 4 years of follow-up in a large cohort of patients with refractory gastroparesis (with video). Gastrointest Endosc 2022; 96: 487-499
• 22 Labonde A, Lades G, Debourdeau A. et al. Gastric peroral endoscopic myotomy in refractory gastroparesis: long-term outcomes and predictive score to improve patient selection. Gastrointest Endosc 2022; 96: 500-508.e2
• 23 Abdelfatah MM, Noll A, Kapil N. et al. Long-term outcome of gastric per-oral endoscopic pyloromyotomy in treatment of gastroparesis. Clin Gastroenterol Hepatol 2021; 19: 816-824
• 24 Kim HK, DeCicco J, Prasad R. et al. Pyloric impedance planimetry during endoscopic per-oral pyloromyotomy guides myotomy extent. J Gastrointest Surg 2025; 29: 101856
• 25 Williams AE, Bhanat E, Seerapu VN. et al. Gastric peroral pyloromyotomy effectiveness in management of all types of gastroparesis. J Gastrointest Surg 2025; 29: 102031
• 26 Malik Z, Kataria R, Modayil R. et al. Gastric per oral endoscopic myotomy (G-POEM) for the treatment of refractory gastroparesis: early experience. Dig Dis Sci 2018; 63: 2405-2412
• 27 Mohan BP, Chandan S, Jha LK. et al. Clinical efficacy of gastric per-oral endoscopic myotomy (G-POEM) in the treatment of refractory gastroparesis and predictors of outcomes: a systematic review and meta-analysis using surgical pyloroplasty as a comparator group. Surg Endosc 2020; 34: 3352-3367
• 28 Eriksson SE, Zheng P, Morton S. et al. Predictors of favorable outcome after pyloroplasty for gastroparesis: should response to pyloric dilation or Botox injection be used as a marker of surgical outcome?. Surg Endosc 2023; 37: 4360-4369
• 29 Li P, Ma B, Gong S. et al. Gastric per-oral endoscopic myotomy for refractory gastroparesis: a meta-analysis. J Gastrointest Surg 2021; 25: 1108-1116
• 30 Uemura KL, Chaves D, Bernardo WM. et al. Peroral endoscopic pyloromyotomy for gastroparesis: a systematic review and meta-analysis. Endosc Int Open 2020; 8: E911-E923